Analysis of Primary Hyperparathyroidism Screening Among US Veterans With Kidney Stones.

ABSTRACT:

Importance

Approximately 3% to 5% of patients with kidney stones have primary hyperparathyroidism (PHPT), a treatable cause of recurrent stones. However, the rate of screening for PHPT in patients with kidney stones remains unknown.

Objectives

To estimate the prevalence of parathyroid hormone (PTH) testing in veterans with kidney stones and hypercalcemia and to identify the demographic, geographic, and clinical characteristics of veterans who were more or less likely to receive PTH testing.

Design, setting, and participants

This cohort study obtained Veterans Health Administration (VHA) health records from the Corporate Data Warehouse for veterans who received care in 1 of the 130 VHA facilities across the United States from January 1, 2008, through December 31, 2013.

SUBMITTER: Ganesan C 

PROVIDER: S-EPMC7391180 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature